APA (7th ed.) Citation

Francke, K., Baumann, S., Gashaw, I., Klein, S., Rohde, B., Zolk, O., . . . Friedrich, C. Safety, Tolerability, and Pharmacokinetics of Filapixant, a Highly Selective P2X3 Receptor Antagonist, in an Ascending-Single-Dose First-in-Human Study. MDPI AG.

Chicago Style (17th ed.) Citation

Francke, Klaus, Sybille Baumann, Isabella Gashaw, Stefan Klein, Beate Rohde, Oliver Zolk, Oliver M. Fischer, and Christian Friedrich. Safety, Tolerability, and Pharmacokinetics of Filapixant, a Highly Selective P2X3 Receptor Antagonist, in an Ascending-Single-Dose First-in-Human Study. MDPI AG.

MLA (9th ed.) Citation

Francke, Klaus, et al. Safety, Tolerability, and Pharmacokinetics of Filapixant, a Highly Selective P2X3 Receptor Antagonist, in an Ascending-Single-Dose First-in-Human Study. MDPI AG.